Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zaccheaus A Jeremiah, Yetunde Obazee, Godwin R Okogun, Teddy C Adias, Osaro Mgbere & Ekere J Essien. (2012) Impact of short-term antiretroviral therapy (START) on some fibrinolytic markers in HIV-infected Nigerian adults: preliminary findings from the START study. HIV/AIDS - Research and Palliative Care 4, pages 87-94.
Read now
Read now
Articles from other publishers (22)
Anjan K. Bongoni, David Kiermeir, Jonas Schnider, Hansjörg Jenni, Pavan Garimella, Andrea Bähr, Nikolai Klymiuk, Eckhard Wolf, David Ayares, Esther Voegelin, Mihai A. Constantinescu, Jörg D Seebach & Robert Rieben. (2015) Transgenic Expression of Human CD46 on Porcine Endothelium. Transplantation 99:10, pages 2061-2069.
Crossref
Crossref
Eulalia Valle-Garay, Angel H. Montes, Jose R. Corte, Alvaro Meana, Joshua Fierer & Victor Asensi. (2013) tPA Alu (I/D) Polymorphism Associates With Bacterial Osteomyelitis. The Journal of Infectious Diseases 208:2, pages 218-223.
Crossref
Crossref
Andrey A. Komissarov, Galina Florova & Steven Idell. (2011) Effects of Extracellular DNA on Plasminogen Activation and Fibrinolysis. Journal of Biological Chemistry 286:49, pages 41949-41962.
Crossref
Crossref
Maarten Dewilde, Britt Van De Craen, Griet Compernolle, Jeppe B. Madsen, Sergei Strelkov, Ann Gils & Paul J. Declerck. (2010) Subtle structural differences between human and mouse PAI-1 reveal the basis for biochemical differences. Journal of Structural Biology 171:1, pages 95-101.
Crossref
Crossref
Diana A. Gorog. (2010) Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease. Journal of the American College of Cardiology 55:24, pages 2701-2709.
Crossref
Crossref
Boguslaw Lipinski. (2009) Modification of fibrin structure as a possible cause of thrombolytic resistance. Journal of Thrombosis and Thrombolysis 29:3, pages 296-298.
Crossref
Crossref
Anna M Thøgersen, Torbjörn K Nilsson, Lars Weinehall, Kurt Boman, Mats Eliasson, Göran Hallmans & Jan-Håkan Jansson. (2009) Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years. Blood Coagulation & Fibrinolysis 20:5, pages 340-346.
Crossref
Crossref
M. Dewilde, S.V. Strelkov, A. Rabijns & P.J. Declerck. (2009) High quality structure of cleaved PAI-1-stab. Journal of Structural Biology 165:2, pages 126-132.
Crossref
Crossref
Andrey A. Komissarov, Aiwu Zhou & Paul J. Declerck. (2007) Modulation of Serpin Reaction through Stabilization of Transient Intermediate by Ligands Bound to α-Helix F. Journal of Biological Chemistry 282:36, pages 26306-26315.
Crossref
Crossref
Fang-Ping Chen. (2006) Hormone Therapy and Cardiovascular Disease. Taiwanese Journal of Obstetrics and Gynecology 45:4, pages 287-293.
Crossref
Crossref
Li-Fen Teng, Fang-Ping Chen & Ning Lee. (2004) Changes in Hemostasis and Lipid Metabolism in Postmenopausal Women Receiving Hormone Replacement Therapy: Effects of Natural and Synthetic Progestogens. Taiwanese Journal of Obstetrics and Gynecology 43:2, pages 80-87.
Crossref
Crossref
K. Verbeke, A. Gils & P.J. Declerck. (2004) Inhibition of plasminogen activator inhibitor‐1: antibody fragments and their unique sequences as a tool for the development of profibrinolytic drugs. Journal of Thrombosis and Haemostasis 2:2, pages 298-305.
Crossref
Crossref
K. Verbeke, A. Gils & P.J. Declerck. (2004) Cloning and paratope analysis of an antibody fragment, a rational approach for the design of a PAI‐1 inhibitor. Journal of Thrombosis and Haemostasis 2:2, pages 289-297.
Crossref
Crossref
Wai-Yee Li, Sheree S. N. Chong, Eunice Y. Huang & Tai-Lan Tuan. (2003) Plasminogen activator/plasmin system: A major player in wound healing?. Wound Repair and Regeneration 11:4, pages 239-247.
Crossref
Crossref
Stefan Verheyden, Alain Sillen, Ann Gils, Paul J. Declerck & Yves Engelborghs. (2003) Tryptophan Properties in Fluorescence and Functional Stability of Plasminogen Activator Inhibitor 1. Biophysical Journal 85:1, pages 501-510.
Crossref
Crossref
Ann-Pascale Bijnens, Ann Gils, Jan M. Stassen, Andrey A. Komissarov, Isabelle Knockaert, Els Brouwers, Joseph D. Shore & Paul J. Declerck. (2001) The Distal Hinge of the Reactive Site Loop and Its Proximity. Journal of Biological Chemistry 276:48, pages 44912-44918.
Crossref
Crossref
Fang-Ping Chen, Ning Lee, Yung-Kui Soong & Ko-En Huang. (2001) Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on cardiovascular risk factors. Menopause 8:5, pages 347-352.
Crossref
Crossref
Thu-Hoa Ngo, Marc F. Hoylaerts, Isabelle Knockaert, Els Brouwers & Paul J. Declerck. (2001) Identification of a Target Site in Plasminogen Activator Inhibitor-1 That Allows Neutralization of Its Inhibitory Properties Concomitant with an Allosteric Up-regulation of Its Antiadhesive Properties. Journal of Biological Chemistry 276:28, pages 26243-26248.
Crossref
Crossref
Å. Johansson, K. Boman, K. Cederquist, H. Forsberg & T. Olsson. (2001) Increased levels of tPA antigen and tPA/PAI‐1 complex in myotonic dystrophy. Journal of Internal Medicine 249:6, pages 503-510.
Crossref
Crossref
F. Bachmann. 2001. Fibrinolytics and Antifibrinolytics. Fibrinolytics and Antifibrinolytics
3
23
.
H. Roger Lijnen, Begona Arza, Berthe Van Hoef, Désiré Collen & Paul J. Declerck. (2000) Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3). Journal of Biological Chemistry 275:48, pages 37645-37650.
Crossref
Crossref
Alice H. Lichtenstein. (2000) Dietary Trans Fatty Acid. Journal of Cardiopulmonary Rehabilitation 20:3, pages 143-146.
Crossref
Crossref